Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Operating Expenses | 2,360 | 1,558 | 1,722 | 2,328 | 2,475 |
Operating Income | -2,360 | -1,558 | -1,722 | -2,328 | -2,473 |
Other Income | -164 | 1,763 | 0 | 0 | -116 |
Pre-tax Income | -2,524 | 205 | -1,722 | -2,328 | -2,589 |
Net Income Continuous | -2,524 | 205 | -1,722 | -2,328 | -2,589 |
Net Income Discontinuous | N/A | N/A | N/A | N/A | -2,373 |
Net Income | $-2,524 | $205 | $-1,722 | $-2,328 | $-4,962 |
EPS Basic Total Ops | -6.96 | 0.84 | -8.04 | -11.76 | -28.47 |
EPS Basic Continuous Ops | -7.04 | 0.81 | -7.99 | -11.73 | -12.61 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -14.77 |
EPS Diluted Total Ops | -6.96 | 0.84 | -8.04 | -11.76 | -28.47 |
EPS Diluted Continuous Ops | -7.04 | 0.81 | -7.99 | -11.73 | -12.61 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -14.77 |
EBITDA(a) | $-2,284 | $-1,484 | $-1,646 | $-2,252 | $-2,370 |